This paper describes the collection, standardisation and checking of cancer survival data included in the EUROCARE-4 database. Methods for estimating relative survival are also described. Incidence and vital status data on newly diagnosed European cancer cases were received from93 cancer registries in 23 countries, covering 151,400,000 people (35% of the participating country population).The third revision of the International Classification ofDiseases for Oncology was used to specify tumour topography and morphology. Records were extensively checked for consistency and compatibility usingmultiple routines; flagged recordswere sent back for correction. An algorithm assigned standardised sequence numbers to multiple cancers.Only firstmalignant cancerswere usedto estimate relative survival fromregistry, year, sex and age-specific life tables. Age-adjusted and Europe-wide survival were also estimated. The database contains 13,814,573 cases diagnosed in 1978-2002; 92%malignant. A negligible proportion of recordswas excluded for major errors. Of 5,753,934 malignant adult cases diagnosed in 1995-2002, 5.3% were second or later cancers, 2.7% were known from death certificates only and 0.4% were discovered at autopsy. The remaining 5,278,670 cases entered the survival analyses, 90% of these had microscopic confirmation and 1.3% were censored alive after less than five years' follow-up. These indicators suggest satisfactory data quality that has improved since EUROCARE-3.

The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis

Ferretti, S.
Membro del Collaboration Group
;
2009

Abstract

This paper describes the collection, standardisation and checking of cancer survival data included in the EUROCARE-4 database. Methods for estimating relative survival are also described. Incidence and vital status data on newly diagnosed European cancer cases were received from93 cancer registries in 23 countries, covering 151,400,000 people (35% of the participating country population).The third revision of the International Classification ofDiseases for Oncology was used to specify tumour topography and morphology. Records were extensively checked for consistency and compatibility usingmultiple routines; flagged recordswere sent back for correction. An algorithm assigned standardised sequence numbers to multiple cancers.Only firstmalignant cancerswere usedto estimate relative survival fromregistry, year, sex and age-specific life tables. Age-adjusted and Europe-wide survival were also estimated. The database contains 13,814,573 cases diagnosed in 1978-2002; 92%malignant. A negligible proportion of recordswas excluded for major errors. Of 5,753,934 malignant adult cases diagnosed in 1995-2002, 5.3% were second or later cancers, 2.7% were known from death certificates only and 0.4% were discovered at autopsy. The remaining 5,278,670 cases entered the survival analyses, 90% of these had microscopic confirmation and 1.3% were censored alive after less than five years' follow-up. These indicators suggest satisfactory data quality that has improved since EUROCARE-3.
De Angelis, Roberta; Francisci, Silvia; Baili, Paolo; Marchesi, Francesca; Roazzi, Paolo; Belot, Aurã©lien; Crocetti, Emanuele; Pury, Pierre; Knijn, Arnold; Coleman, Michel; Capocaccia, Riccardo; Holub, J.; Jurickova, L.; Storm, H. H.; Engholm, G.; Hakulinen, T.; Belot, A.; Hã©delin, G.; Velten, M.; Tron, I.; Le Gall, E.; Launoy, G.; Guizard, A. V.; Faivre, J.; Bouvier, A. M.; Carli, P. M.; Maynadiã©, M.; Danzon, A.; Buemi, A.; Tretarre, B.; Lacour, B.; Desandes, E.; Colonna, M.; Moliniã©, F.; Bara, S.; Schvartz, C.; Ganry, O.; Grosclaude, P.; Brenner, H.; Kaatsch, P.; Ziegler, H.; Tryggvadottir, L.; Comber, H.; Berrino, F.; Allemani, C.; Baili, P.; Ciampichini, R.; Ciccolallo, L.; Gatta, G.; Micheli, A.; Sant, M.; Sowe, S.; Zigon, G.; Tagliabue, G.; Contiero, P.; Bellã¹, F.; Giacomin, A.; Ferretti, S.; Dal Maso, D. Serraino L.; De Dottori, M.; De Paoli, A.; Zanier, L.; Vercelli, M.; Orengo, M. A.; Casella, C.; Quaglia, A.; Pannelli, F.; Federico, M.; Rashid, I.; Cirilli, C.; Fusco, M.; Traina, A.; De Lisi, V.; Bozzani, F.; Magnani, C.; Pastore, G.; Tumino, R.; La Rosa, M. G.; Spata, E.; Sigona, A.; Mangone, L.; Falcini, F.; Foca, F.; Giorgetti, S.; Senatore, G.; Iannelli, A.; Budroni, M.; Zanetti, R.; Patriarca, S.; Rosso, S.; Piffer, S.; Franchini, S.; Paci, E.; Crocetti, E.; La Rosa, F.; Stracci, F.; Cassetti, T.; Zambon, P.; Guzzinati, S.; Caldora, M.; Capocaccia, R.; Carrani, E.; Francisci, S.; Grande, E.; Inghelmann, R.; Lenz, H.; Martina, L.; Roazzi, P.; Santaquilani, M.; Simonetti, A.; Tavilla, A.; Verdecchia, A.; Dalmas, M.; Langmark, F.; Bray, F.; Johannesen, T. B.; Rachtan, J.; Gã³åºdåº, S.; Siudowska, U.; Mè©zyk, R.; Bielska-Lasota, M.; Zwierko, M.; Pinheiro, P. S.; Primic-Žakelj, M. P. -. Z.; Mateos, A.; Izarzugaza, I.; Torrella-Ramos, A.; Zurriaga, Oscar; Marcos-Gragera, R.; Vilardell, M. L.; Izquierdo, A.; Martinez-Garcia, C.; Sã¡nchez, M. J.; Navarro, C.; Chirlaque, M. D.; Peris-Bonet, R.; Ardanaz, E.; Moreno, C.; Galceran, J.; Klint, Ã. .; Talbã¤ck, M.; Jundt, G.; Usel, M.; Frick, H.; Ess, S. M.; Bordoni, A.; Luthi, J. C.; Konzelmann, I.; Probst, N.; Lutz, J. M.; Pury, P.; Visser, O.; Otter, R.; Schaapveld, M.; Coebergh, J. W. W.; Janssen-Heijnen, M. L.; Van Der Heijden, Louis; Greenberg, D. C.; Coleman, M. P.; Woods, Laura; Moran, T.; Forman, D.; Cooper, N.; Roche, M.; Verne, J.; Mã¸ller, H.; Meechan, D.; Poole, J.; Lawrence, G.; Stiller, C.; Gavin, A.; Black, R. J.; Brewster, D. H.; Steward, J. A.; Oberaigner, W.; Hackl, M.; Van Eycken, E.; Verstreken, Martine
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2380616
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 118
  • ???jsp.display-item.citation.isi??? 113
social impact